nope, you argued that ropren would never be given approval by the RMOH and would demand an expensive phase 3 clinical trial. a manufacturing license is a completely different issue. dont worry tharlow, i dont think anyone here expected you to live up to you word. you have zero credibility. back on igniore for you.
- Forums
- ASX - By Stock
- heading lower on profit taking
nope, you argued that ropren would never be given approval by...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online